Third Temporary Extension Of COVID-19 Telemedicine Flexibilities For Prescription Of Controlled Medications

On November 19, 2024, the U.S. Department of Health and Human Services (HHS) published this third temporary extension of COVID-19 telemedicine flexibilities for prescription of controlled medications. This rule is effective January 1, 2025, through December 31, 2025. Through this extension, a prescribing health care professional—subject to certain exceptions—may continue to prescribe controlled medications to a consumer only after conducting an in-person evaluation of that individual . . .